To tackle these concerns, we performed subgroup analyses based on the medium (either plasma or serum) and the type of antibody clone (e.g., L1CAM clone UJ127 or 5G3) for the analyses for patients with PD vs HCs. The gene discussed is L1CAM; the disease is Parkinson disease.